REVATHY B IYER to Recombinant Fusion Proteins
This is a "connection" page, showing publications REVATHY B IYER has written about Recombinant Fusion Proteins.
Connection Strength
0.016
-
Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer. Lancet Oncol. 2011 Nov; 12(12):1109-17.
Score: 0.016
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.